William Blair Initiates Coverage On ARS Pharmaceuticals with Outperform Rating

William Blair analyst Tim Lugo initiates coverage on ARS Pharmaceuticals (NASDAQ:SPRY) with a Outperform rating.

William Blair analyst Tim Lugo initiates coverage on ARS Pharmaceuticals (NASDAQ:SPRY) with a Outperform rating.

Total
0
Shares
Related Posts